Induction Healthcare Group PLC Change of Adviser (0995R)
March 04 2021 - 2:00AM
UK Regulatory
TIDMINHC
RNS Number : 0995R
Induction Healthcare Group PLC
04 March 2021
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Change of Adviser
Appointment of N+1 Singer as Nominated Adviser & Sole
Broker
Induction Healthcare (AIM: INHC), a leading healthcare
technology company that helps to digitally transform hospitals,
announces the appointment of N+1 Singer as Nominated Adviser and
Sole Broker with immediate effect.
ENQUIRIES
Induction Healthcare https://inductionhealthcare.com
Dr Hugo Stephenson, Joint Chief Via Walbrook PR
Executive Officer
James Balmain, Joint Chief Executive
Officer
N+1 Singer (Nominated Adviser
and Broker) +44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd +44 (0)20 7933 8780 or induction@walbrookpr.com
+44 (0)7980 541 893 / +44 (0)7407
Paul McManus / Alice Woodings 804 654
About Induction Healthcare - https://inductionhealthcare.com
Induction Healthcare (AIM: INHC) is a UK-based leading
healthcare technology company enabling the digital transformation
of hospitals. We make a range of time-saving tools that work with
existing hospital IT systems, benefitting staff and patients, while
ensuring the highest standards of clinical safety and information
security.
More than 190,000 hospital doctors across multiple territories,
including the UK, Ireland, Australia and South Africa, as well as a
rapidly growing number of more than 150,000 patients, choose
Induction platforms.
Induction Switch is the number one healthcare collaboration app
in the UK, used by the majority of hospital doctors within the NHS.
The app helps to increase productivity and enhance communication by
securely sharing phone numbers and bleeps, bookmarks, documents and
messages in a clinical setting.
Induction Guidance provides medical organisations, including
most hospital trusts within the NHS, with the ability to
collaboratively create, edit, and publish their own local medical
guidelines in a secure and locally administrated environment. This
increases knowledge of, and adherence to, guidance.
Induction Zesty is a market-leading digital platform for
patients visiting hospitals. The platform allows patients to book
and access their appointments, read their clinical letters, store a
copy of their clinical record and provide data to their care teams
remotely. It is not just a compelling patient experience, but also
delivers significant cost benefits to hospitals.
Induction HealthStream is a proprietary data integration
platform that reads and writes patient demographic, appointment and
clinical record data between a growing number of hospital EHR
systems and the Induction platforms. This connectivity between
stakeholders and legacy IT systems adds substantial value to
pre-existing health IT investment and allows large-scale adoption
of Induction app-based services.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
APPDZGGFLFNGMZM
(END) Dow Jones Newswires
March 04, 2021 02:00 ET (07:00 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024